Deferoxamine pharmacokinetics
- 1 January 2001
- journal article
- research article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 63-68
- https://doi.org/10.1016/s0037-1963(01)90061-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Trial to Investigate the Relationship between DFO Pharmacokinetics and Metabolism and DFO‐Related ToxicityAnnals of the New York Academy of Sciences, 1998
- Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detectionAnalytical Biochemistry, 1992
- Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: Choice of complexing agent and application to biological fluidsAnalytical Biochemistry, 1990
- Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.British Journal of Clinical Pharmacology, 1987
- Transfusion and Exchange Transfusion in Sickle Cell Anaemias, with Particular Reference to Iron MetabolismActa Haematologica, 1987
- Ocular changes in patients undergoing long-term desferrioxamine treatment.British Journal of Ophthalmology, 1984
- Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded SubjectsBritish Journal of Haematology, 1979
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976